
Currently out of the existing stock ratings of Donald Ellis, 35 are a BUY (94.59%), 2 are a HOLD (5.41%).
Analyst Donald Ellis, has had 57.42% of price targets met with an average potential upside of 60.1%, reached in 532 days on average. Previously, Donald Ellis worked at JMP.
Donald Ellis has documented 75 price targets and ratings displayed on 12 stocks. The coverage was on Healthcare, Technology sectors.
Most recent stock forecast was given on CLS, Celestica at 21-Dec-2021.
Analyst best performing recommendations are on OCUL (OCULAR THERAPEUTIX).
The best stock recommendation documented was for OCUL (OCULAR THERAPEUTIX) on 11/12/2019. The price target of $7 was fulfilled within 113 days with a profit of $4.43 (172.37%), with a performance score of 15.25.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 27-May-2025
$3
$-0.61 (-16.90%)
$8
3 days ago
(16-Nov-2026)
Buy Since 13-May-2025
$16
$12.39 (343.21%)
$16
23 days ago
(27-Oct-2026)
0/11 (0%)
$12.21 (322.16%)
Hold Since 05-Nov-2024
$4
$0.39 (10.80%)
$3
6 months 12 days ago
(07-May-2026)
4/5 (80%)
$-0.93 (-18.86%)
50
Buy Since 04-May-2026
$11
$7.39 (204.71%)
$6
6 months 15 days ago
(04-May-2026)
1/2 (50%)
$6.25 (131.58%)
391
Buy Since 28-Nov-2016
$12
$8.39 (232.41%)
6 months 15 days ago
(04-May-2026)
0/2 (0%)
$7.25 (152.63%)